CiRC Biosciences

Chicago, IL · Founded 2019 · Privately Held (backing)

Developer of cell-based therapies designed to offer treatments for serious diseases with high unmet needs, with an initial focus on blindness. CiRC Biosciences is based in Chicago, IL and was founded in 2019. Its last reported valuation was $24 million in Dec 2020. It has raised $39.1 million across 2 recorded rounds; the latest was a $7 million debt round in Apr 2024.

Last reported valuation
$24.0M
Oct 2026
Priced at
—
Total raised
$39.1M
Last round
Debt
Apr 2024
What is CiRC Biosciences worth?
$24.0Mlast reported valuation · Oct 2026

CiRC Biosciences's last reported valuation, Dec 2020. Nothing priced has surfaced since.

Free account
More of CiRC Biosciences with a free account
  • ·Watch CiRC Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

CiRC Biosciences funding history

2 rounds
DateRoundRaisedPost-money
Apr 2024Debt$7.0M▮
Feb 2024Seed Round$250K▮
Unlock post-money valuations

Membership and data by Private Market View

CiRC Biosciences valuation

CiRC Biosciences's last reported valuation was $24 million in Dec 2020. No priced round, secondary trade or fund mark has surfaced since.

How much has CiRC Biosciences raised?

CiRC Biosciences has raised $39.1 million in total; 2 of its rounds are on record. The largest on record was a $7 million debt round in Apr 2024.

CiRC Biosciences has filed 2 Form Ds with the SEC, most recently in Oct 2024 ($250,000 sold to 1 investor).

How CiRC Biosciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For CiRC Biosciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about CiRC Biosciences

What is CiRC Biosciences worth?
CiRC Biosciences is valued at $24.0M as of Oct 2026. CiRC Biosciences's last reported valuation, Dec 2020. Nothing priced has surfaced since.
How much has CiRC Biosciences raised?
CiRC Biosciences has raised $39.1M in total funding across 2 recorded rounds.
When did CiRC Biosciences last raise?
CiRC Biosciences last raised in Apr 2024 (Debt), raising $7.0M.